HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 86.2%

Neg 0% Neu 86.2% Pos 0%

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $15 price target.